14-67729248-G-T
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM2PM5PP3_StrongPP5_Very_Strong
The NM_152443.3(RDH12):c.716G>T(p.Arg239Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000657 in 152,176 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R239G) has been classified as Likely pathogenic.
Frequency
Consequence
NM_152443.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RDH12 | NM_152443.3 | c.716G>T | p.Arg239Leu | missense_variant | 8/9 | ENST00000551171.6 | NP_689656.2 | |
RDH12 | XM_047430965.1 | c.716G>T | p.Arg239Leu | missense_variant | 8/9 | XP_047286921.1 | ||
ZFYVE26 | XM_047431173.1 | c.*494C>A | 3_prime_UTR_variant | 42/42 | XP_047287129.1 | |||
GPHN | XM_047430879.1 | c.1313-5947G>T | intron_variant | XP_047286835.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RDH12 | ENST00000551171.6 | c.716G>T | p.Arg239Leu | missense_variant | 8/9 | 1 | NM_152443.3 | ENSP00000449079.1 | ||
RDH12 | ENST00000267502.3 | c.716G>T | p.Arg239Leu | missense_variant | 7/8 | 5 | ENSP00000267502.3 | |||
ZFYVE26 | ENST00000394455.6 | n.3251C>A | non_coding_transcript_exon_variant | 14/15 | 2 | |||||
RDH12 | ENST00000552873.1 | n.85G>T | non_coding_transcript_exon_variant | 2/2 | 5 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152176Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000403 AC: 1AN: 248206Hom.: 0 AF XY: 0.00000743 AC XY: 1AN XY: 134528
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1457704Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 725278
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152176Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74340
ClinVar
Submissions by phenotype
Leber congenital amaurosis Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jul 22, 2024 | Variant summary: RDH12 c.716G>T (p.Arg239Leu) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4e-06 in 248206 control chromosomes. c.716G>T has been reported in the literature in homozygous or compound heterozygous individuals affected with Leber Congenital Amaurosis (e.g. Schlottmann_2023, Daich Varela_2024, Jin_2022, Sharon_2020, Zanolli_2020). These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 37714431, 35006499, 37217489, 31456290, 32141364). ClinVar contains an entry for this variant (Variation ID: 536988). Based on the evidence outlined above, the variant was classified as likely pathogenic. - |
Likely pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Oct 07, 2021 | - - |
Retinitis pigmentosa Pathogenic:2
Likely pathogenic, no assertion criteria provided | research | Sharon lab, Hadassah-Hebrew University Medical Center | Jun 23, 2019 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | DBGen Ocular Genomics | Jun 21, 2021 | - - |
Leber congenital amaurosis 13 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 29, 2023 | For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Arg239 amino acid residue in RDH12. Other variant(s) that disrupt this residue have been observed in individuals with RDH12-related conditions (PMID: 16269441, 24474277), which suggests that this may be a clinically significant amino acid residue. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on RDH12 protein function. ClinVar contains an entry for this variant (Variation ID: 536988). This missense change has been observed in individual(s) with autosomal recessive inherited retinal dystrophy and/or Leber congenital amaurosis (PMID: 31456290, 32141364, 35006499; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change replaces arginine, which is basic and polar, with leucine, which is neutral and non-polar, at codon 239 of the RDH12 protein (p.Arg239Leu). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at